142 related articles for article (PubMed ID: 17108012)
1. Identification of ganglion cell neurites in human subretinal and epiretinal membranes.
Lewis GP; Betts KE; Sethi CS; Charteris DG; Lesnik-Oberstein SY; Avery RL; Fisher SK
Br J Ophthalmol; 2007 Sep; 91(9):1234-8. PubMed ID: 17108012
[TBL] [Abstract][Full Text] [Related]
2. Ganglion cell neurites in human idiopathic epiretinal membranes.
Lesnik Oberstein SY; Lewis GP; Chapin EA; Fisher SK
Br J Ophthalmol; 2008 Jul; 92(7):981-5. PubMed ID: 18577651
[TBL] [Abstract][Full Text] [Related]
3. Cell proliferation in human epiretinal membranes: characterization of cell types and correlation with disease condition and duration.
Oberstein SY; Byun J; Herrera D; Chapin EA; Fisher SK; Lewis GP
Mol Vis; 2011; 17():1794-805. PubMed ID: 21750605
[TBL] [Abstract][Full Text] [Related]
4. Evidence that neurites in human epiretinal membranes express melanopsin, calretinin, rod opsin and neurofilament protein.
Lesnik Oberstein SY; Lewis GP; Dutra T; Fisher SK
Br J Ophthalmol; 2011 Feb; 95(2):266-72. PubMed ID: 20971788
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy.
Ioachim E; Stefaniotou M; Gorezis S; Tsanou E; Psilas K; Agnantis NJ
Eur J Ophthalmol; 2005; 15(3):384-91. PubMed ID: 15945009
[TBL] [Abstract][Full Text] [Related]
6. Changes in retinal gene expression in proliferative vitreoretinopathy: glial cell expression of HB-EGF.
Hollborn M; Tenckhoff S; Jahn K; Iandiev I; Biedermann B; Schnurrbusch UE; Limb GA; Reichenbach A; Wolf S; Wiedemann P; Kohen L; Bringmann A
Mol Vis; 2005 Jun; 11():397-413. PubMed ID: 15988409
[TBL] [Abstract][Full Text] [Related]
7. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
8. Expression of wild-type p53-induced phosphatase 1 in diabetic epiretinal membranes.
Xu J; Zhong H; Cui L; Lan Q; Chen L; He W; Wu Y; Jiang L; Huang H; Zhao X; Li L; Zeng S; Li M; Xu F
Oncotarget; 2017 May; 8(22):35532-35541. PubMed ID: 28402943
[TBL] [Abstract][Full Text] [Related]
9. Coexpression of VEGF receptors VEGF-R2 and neuropilin-1 in proliferative diabetic retinopathy.
Ishida S; Shinoda K; Kawashima S; Oguchi Y; Okada Y; Ikeda E
Invest Ophthalmol Vis Sci; 2000 Jun; 41(7):1649-56. PubMed ID: 10845581
[TBL] [Abstract][Full Text] [Related]
10. A comparison of hypoxia-inducible factor-α in surgically excised neovascular membranes of patients with diabetes compared with idiopathic epiretinal membranes in nondiabetic patients.
Lim JI; Spee C; Hinton DR
Retina; 2010 Oct; 30(9):1472-8. PubMed ID: 20811317
[TBL] [Abstract][Full Text] [Related]
11. Diverse NF-kappaB expression in epiretinal membranes after human diabetic retinopathy and proliferative vitreoretinopathy.
Harada C; Harada T; Mitamura Y; Quah HM; Ohtsuka K; Kotake S; Ohno S; Wada K; Takeuchi S; Tanaka K
Mol Vis; 2004 Jan; 10():31-6. PubMed ID: 14737065
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical analysis of the internal limiting membrane peeled with infracyanine green.
La Heij EC; Dieudonné SC; Mooy CM; Diederen RM; Liem AT; van Suylen RJ; Hendrikse F
Am J Ophthalmol; 2005 Dec; 140(6):1123-5. PubMed ID: 16376661
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes.
Tsanou E; Ioachim E; Stefaniotou M; Gorezis S; Charalabopoulos K; Bagli H; Peschos D; Psilas K; Agnantis NJ
Int J Clin Pract; 2005 Oct; 59(10):1157-61. PubMed ID: 16178982
[TBL] [Abstract][Full Text] [Related]
14. [Pathomorphology of membranes appearing in proliferative vitreoretinopathies].
Laudańska-Olszewska I; Omulecki W; Dziegielewski K; Pikulski Z; Omulecka A
Klin Oczna; 2006; 108(1-3):28-31. PubMed ID: 16883935
[TBL] [Abstract][Full Text] [Related]
15. Fibrocontractive Müller cell phenotypes in proliferative diabetic retinopathy.
Guidry C; King JL; Mason JO
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1929-39. PubMed ID: 19117921
[TBL] [Abstract][Full Text] [Related]
16. Characterization of cells from patient-derived fibrovascular membranes in proliferative diabetic retinopathy.
Kim LA; Wong LL; Amarnani DS; Bigger-Allen AA; Hu Y; Marko CK; Eliott D; Shah VA; McGuone D; Stemmer-Rachamimov AO; Gai X; D'Amore PA; Arboleda-Velasquez JF
Mol Vis; 2015; 21():673-87. PubMed ID: 26120272
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes.
Vinores SA; Campochiaro PA; Conway BP
Invest Ophthalmol Vis Sci; 1990 Jan; 31(1):14-28. PubMed ID: 1688833
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactive ET-1 in the vitreous humor and epiretinal membranes of patients with proliferative vitreoretinopathy.
Roldán-Pallarés M; Rollín R; Mediero A; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Mol Vis; 2005 Jul; 11():461-71. PubMed ID: 16030497
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression.
Zhang X; Barile G; Chang S; Hays A; Pachydaki S; Schiff W; Sparrow J
Curr Eye Res; 2005 May; 30(5):395-403. PubMed ID: 16020270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
